Revolution Medicines, Inc. (RVMD)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch RVMD
See up to 3 months of RVMD. The 7-day demo opens the 1M and 3M ranges and puts RVMD on your watchlist.
Start 7-day demoLatest RVMD insider trades
About Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. files with the SEC under CIK 0001628171 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
RVMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 79 | 380,710 | $78.01M |
| Option exercise | 18 | 504,730 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RVMD insider transactions (Form 4)
103103 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jack Anders - Officer | Open-market sale | Common Stock | 2,722 | $156.12 footnote F2 | $425K | |
| ||||||
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 4,175 | $156.12 footnote F2 | $652K | |
| ||||||
 Margaret A. Horn - Officer | Option exercise | Common Stock | 3,302 | $29.80 | $98K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 25,725 | $26.50 | $682K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 29,600 | $160.12 footnote F7 | $4.74M | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 15,546 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 44,854 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 573 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 3,302 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 25,725 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 15,546 | $40.74 | $633K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 44,854 | $29.80 | $1.34M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 60,400 | $160.17 footnote F3 | $9.67M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 3,575 | $156.12 footnote F5 | $558K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 573 | $40.74 | $23K | |
| ||||||
| Margaret A. Horn - Officer | Option exercise | Common Stock | 8,906 | $40.74 | $363K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 1,315 | $144.28 footnote F4 | $190K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 885 | $145.15 footnote F5 | $128K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 700 | $146.04 footnote F6 | $102K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 500 | $147.27 footnote F7 | $74K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 1,800 | $148.72 footnote F8 | $268K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,600 | $149.64 footnote F9 | $688K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 200 | $150.17 | $30K | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 1,094 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 8,906 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 1,094 | $42.45 | $46K | |
| ||||||
 Anthony Mancini - Officer | Option exercise | Common Stock | 3,121 | $33.62 | $105K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 700 | $153.30 footnote F3 | $107K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 2,000 | $154.06 footnote F4 | $308K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 421 | $154.82 footnote F5 | $65K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 3,121 | $0.00 | - | |
| ||||||
| Anthony Mancini - Officer | Option exercise | Common Stock | 3,120 | $33.62 | $105K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,671 | $131.66 footnote F3 | $220K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,049 | $132.88 footnote F4 | $139K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 400 | $134.34 footnote F5 | $54K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 3,120 | $0.00 | - | |
| ||||||
 Mark A. Goldsmith - Officer | Option exercise | Common Stock | 23,244 | $4.09 | $95K | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 96,756 | $4.73 | $458K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 120,000 | $150.09 footnote F3 | $18.01M | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 23,244 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 96,756 | $0.00 | - | |
| ||||||
| Anthony Mancini - Officer | Option exercise | Common Stock | 37,450 | $33.62 | $1.26M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 1,800 | $93.22 footnote F3 | $168K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 3,128 | $94.16 footnote F4 | $295K | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 21,086 | $95.49 footnote F5 | $2.01M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 11,036 | $96.43 footnote F6 | $1.06M | |
| Anthony Mancini - Officer | Open-market sale | Common Stock | 400 | $97.21 footnote F7 | $39K | |
| Anthony Mancini - Officer | Option exercise | Stock Option (Right to Buy) | 37,450 | $0.00 | - | |
| ||||||
| Lin Wei - Officer | Open-market sale | Common Stock | 2,073 | $99.48 | $206K | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 4,302 | $99.48 | $428K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 12,871 | $99.48 | $1.28M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 4,583 | $99.48 | $456K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 2,753 | $99.48 | $274K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,795 | $99.48 | $179K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 1,163 | $97.44 | $113K | |
 Xiaolin Wang - Officer | Open-market sale | Common Stock | 2,010 | $99.48 | $200K | |
| Elizabeth M. Anderson | Gift | Common Stock | 15,000 | $0.00 | - | |
| Elizabeth M. Anderson | Gift | Common Stock | 15,000 | $0.00 | - | |
| Xiaolin Wang - Officer | Grant or award | Common Stock | 15,100 | $0.00 | - | |
| Xiaolin Wang - Officer | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Lin Wei - Officer | Grant or award | Common Stock | 15,100 | $0.00 | - | |
| Lin Wei - Officer | Grant or award | Stock Option (Right to Buy) | 34,000 | $0.00 | - | |
| Stephen Michael Kelsey - Officer | Grant or award | Common Stock | 21,100 | $0.00 | - | |
| Stephen Michael Kelsey - Officer | Grant or award | Stock Option (Right to Buy) | 47,600 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 30,000 | $4.09 | $123K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 700 | $98.17 footnote F4 | $69K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,500 | $99.76 footnote F5 | $349K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 3,620 | $100.73 footnote F6 | $365K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 21,329 | $101.60 footnote F7 | $2.17M | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 851 | $102.20 footnote F8 | $87K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 100 | $98.31 | $10K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 400 | $100.12 footnote F11 | $40K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 1,700 | $101.47 footnote F12 | $173K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 800 | $102.00 footnote F13 | $82K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 100 | $98.29 | $10K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 600 | $100.19 footnote F15 | $60K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 2,100 | $101.63 footnote F16 | $213K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 200 | $102.08 | $20K | |
| Mark A. Goldsmith - Officer | Grant or award | Stock Option (Right to Buy) | 128,600 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Grant or award | Common Stock | 57,100 | $0.00 | - | |
| ||||||
| Margaret A. Horn - Officer | Grant or award | Common Stock | 21,100 | $0.00 | - | |
| Margaret A. Horn - Officer | Grant or award | Stock Option (Right to Buy) | 47,600 | $0.00 | - | |
| Jeff Cislini - Officer | Grant or award | Common Stock | 14,500 | $0.00 | - | |
| Jeff Cislini - Officer | Grant or award | Stock Option (Right to Buy) | 32,500 | $0.00 | - | |
| Jack Anders - Officer | Grant or award | Common Stock | 20,200 | $0.00 | - | |
| Jack Anders - Officer | Grant or award | Stock Option (Right to Buy) | 45,400 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Stock Option (Right to Buy) | 24,010 | $0.00 | - | |
| Mark A. Goldsmith - Officer | Option exercise | Common Stock | 24,010 | $0.54 | $13K | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 908 | $115.60 | $105K | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 51,406 | $42.45 | $2.18M | |
| Margaret A. Horn - Officer | Option exercise | Common Stock | 23,594 | $29.80 | $703K | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 53,096 | $100.02 footnote F3 | $5.31M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 20,204 | $101.79 footnote F4 | $2.06M | |
| Margaret A. Horn - Officer | Open-market sale | Common Stock | 1,700 | $102.90 | $175K | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 51,406 | $0.00 | - | |
| Margaret A. Horn - Officer | Option exercise | Stock Option (Right to Buy) | 23,594 | $0.00 | - | |
| ||||||
| Jack Anders - Officer | Option exercise | Common Stock | 10,000 | $42.45 | $425K | |
| Jack Anders - Officer | Open-market sale | Common Stock | 10,000 | $98.00 | $980K | |
| Jack Anders - Officer | Option exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Jeff Cislini - Officer | Open-market sale | Common Stock | 2,688 | $76.82 | $206K | |
| Mark A. Goldsmith - Officer | Open-market sale | Common Stock | 15,394 | $76.82 | $1.18M | |
| Stephen Michael Kelsey - Officer | Open-market sale | Common Stock | 5,447 | $76.82 | $418K | |
Item 2.03, 8.01
Item 1.01, 2.03
Item 8.01
Item 2.02, 9.01
Recent RVMD Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ALAN SANDLER | Officer | 6,309 | $1.27M | View on EDGAR | |
| ANTHONY MANCINI | Officer | 9,363 |
RVMD insider trading FAQ
What is the latest insider trade for RVMD?
Revolution Medicines, Inc. (RVMD) had 18 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for RVMD runs to 103 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RVMD stock?
No insider purchases of RVMD were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling RVMD stock?
79 insider sales of RVMD were filed in the last 90 days, totaling $78.01M.
Where can I see RVMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RVMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Alan B. Sandler view on EDGAR
- - Jeff Cislini view on EDGAR
- - Anthony Mancini view on EDGAR
- - Elizabeth M. Anderson view on EDGAR
- - Anthony Mancini view on EDGAR
- - Alan B. Sandler view on EDGAR
- - Anthony Mancini view on EDGAR
- - Stephen Michael Kelsey view on EDGAR
- - Margaret A. Horn view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where RVMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RVMD with a 7-day demo
- RVMD on your watchlist
- Every RVMD Form 4 filing on record
- Up to 3 months of RVMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
